Atrial Fibrillation
Conditions
Brief summary
The researchers are observing subject and clinician interaction in order to develop future education materials that will help patients and clinicians discuss atrial fibrillation and options to treat it.
Interventions
OTHERFeedback
Study team members will conduct interviews with subjects to gather feedback on Atrial Fibrillation experiences
Sponsors
American Heart Association
Mayo Clinic
Study design
Observational model
COHORT
Time perspective
OTHER
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
1. Must be 18 or older 2. Must have an appointment for Atrial Fibrillation 3. Must not have dementia 4. Must not have severe hearing or vision impairment Patients will be given a written consent Guests that accompany patients will be given an oral consent KER unit PAG members will be given an oral consent
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Interview Process | baseline | The number of subjects to complete the interview process |
Countries
United States
Participant flow
Participants by arm
| Arm | Count |
|---|---|
| Nonvalvular Chronic Atrial Fibrillation (DA4AFib) Subjects who were scheduled for Nonvalvular Chronic Atrial Fibrillation (DA4AFib) treatment at Mayo Clinic Rochester and Mayo Clinic Health System sites in Minnesota
Study team members conducted interviews with subjects to gather feedback on Atrial Fibrillation experiences | 34 |
| Total | 34 |
Baseline characteristics
| Characteristic | Nonvalvular Chronic Atrial Fibrillation (DA4AFib) |
|---|---|
| Age, Categorical <=18 years | 0 Participants |
| Age, Categorical >=65 years | 13 Participants |
| Age, Categorical Between 18 and 65 years | 21 Participants |
| Age, Continuous | 50 years |
| Race (NIH/OMB) American Indian or Alaska Native | 0 Participants |
| Race (NIH/OMB) Asian | 0 Participants |
| Race (NIH/OMB) Black or African American | 0 Participants |
| Race (NIH/OMB) More than one race | 1 Participants |
| Race (NIH/OMB) Native Hawaiian or Other Pacific Islander | 0 Participants |
| Race (NIH/OMB) Unknown or Not Reported | 0 Participants |
| Race (NIH/OMB) White | 33 Participants |
| Region of Enrollment United States | 34 participants |
| Sex: Female, Male Female | 10 Participants |
| Sex: Female, Male Male | 24 Participants |
Adverse events
| Event type | EG000 affected / at risk |
|---|---|
| deaths Total, all-cause mortality | 0 / 0 |
| other Total, other adverse events | 0 / 0 |
| serious Total, serious adverse events | 0 / 0 |
Outcome results
Primary
Interview Process
The number of subjects to complete the interview process
Time frame: baseline
| Arm | Measure | Value (COUNT_OF_PARTICIPANTS) |
|---|---|---|
| Nonvalvular Chronic Atrial Fibrillation (DA4AFib) | Interview Process | 34 Participants |